Dont Skip a Beat Cardiovascular Pharmacotherapy Update Part 1 CV Risk Estimation, Hypertension, Obesity, and Heart Failure

Course overview

At the conclusion of this program, the participant will be able to 1. Explain recommendations from the American College of Cardiology American Heart Association guidelines for treatment of patients with hypertension, and heart failure. 2. Review lifestyle modifications that are recommended for the treatment and prevention of cardiovascular disease. 3. Identify how future cardiovascular risk is estimated in primary prevention patients using the Pooled Cohort Equations and PREVENT calculator. 4. Discuss a care plan for patients with resistant hypertension based on the 2018 American Heart Association scientific statement. 5. List guideline recommendations supporting the use of antiplatelet therapy for primary prevention patients. 6. Summarize the evidence-based CV risk reduction benefits of medications used to treat overweight and obese patients. 7. Describe the pillars of therapy for heart failure. 8. Review results from cardiovascular outcome trials evaluating the use of angiotensin neprilysin inhibition in heart failure with reduced ejection fraction.